Latin America Plasma Protein Therapeutics Market by product type (Immunoglobulins, Albumin, Coagulation Factors, alpha-1 proteinase inhibitor and others) by application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency and others) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

Latin America Plasma Protein Therapeutics Market by product type (Immunoglobulins, Albumin, Coagulation Factors, alpha-1 proteinase inhibitor and others) by application (Hemophilia, Primary Immunodeficiency Disorder, Idiopathic Thrombocytopenic Purpura, Secondary Immunodeficiency and others) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 239 | Pages: 135 | December 2016 | Region: Latin America


The Latin America Plasma Protein Therapeutics Market is valued currently at USD 2.11 Billion in 2015 and is forecasted to be a $3.05 Billion market by 2020 with a significant CAGR of 7.6%. With the increased production of new plasma-derived therapies, the medical application in plasma proteins has increased significantly. With the advancements in technology, the process for fractionating the protein from plasma has become more cost saving and efficient and is supposed to boost the plasma protein therapeutics market. According to WHO reports more than half of the global blood donors belong to high income countries which constitutes 18% of the population. With rising awareness among people regarding blood donations and government initiatives, plasma derived medicine market is expected to grow at a significant rate in the coming years.

Plasma is a fluid rich with proteins and play an important role in providing immunity and blood clotting. Extracting the proteins in plasma can be helpful in carrying out medical therapies for immune deficiencies, autoimmune, bleeding and neurological disorders. These therapies treat the medical conditions by replacing the missing or deficient proteins in plasma. The treatment through plasma protein therapies involves the infusion or injection of the biological medicine to cure life-threatening chronic and genetic diseases.

The market is driven by a host of factors which include increased introduction of new plasma-derived therapies, rise in life threatening diseases which involves immune and neurological systems like chronic inflammatory demyelinating polyneuropathy (CIPD), Ideopathic thrombocytopenic purpura (ITP) and infectious diseases like Hepatitis A&B, Tetanus, Rabies and varicella. However, factors like stringent policies by the government, complexity in manufacturing the proteins reimbursement must be taken care of in order for the market to prosper in the future.

The Latin America Plasma Protein Therapeutics Market                 is categorised based on type of the product as Albumin, Immunoglobulins, alpha-1 proteinase inhibitors and others. By application, the market is segmented as Idiopathic Thrombocytopenic Purpura, Primary Immunodeficiency Disorder, Secondary Immunodeficiency and others. On the basis of geography region, Latin America is categorised as Brazil, Argentina, Mexico and others.

The major companies in the plasma protein therapeutic market are CSL Behring, Grifols, Baxter, Krdrion, Octapharma, China Biologics, Chendu Inst. and Shire Plc.

1. Introduction                                                                                 

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                          

                1.4 General Study Assumptions                                                                

2. Research Methodology                                                                                           

                2.1 Introduction                                                                               

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                           

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                      

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

3. Overview                                                                                       

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                                    

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                                              

5. Market Segmentation                                                                                              

                5.1 By Type                                                                        

                                5.1.1 Immunoglobulins                                                 

                                5.1.2 Albumin                                                   

                                5.1.3 Coagulation Factors                                                             

                                5.1.4 Alpha-1 proteinase inhibitor                                                            

                                5.1.5 Others                                                      

                5.2 By Application                                                                           

                                5.2.1 Hemophilia                                                             

                                5.2.2 Primary Immunodeficiency Disorder                                                           

                                5.2.3 Idiopathic Thrombocytopenic Purpura                                                        

                                5.2.4 Secondary Immunodeficiency                                                        

                                5.2.5 Others                                                      

6. Geographical Analysis                                                                                              

                6.1 Introduction                                                                               

                6.2 Brazil                                                                             

                6.3 Mexico                                                                         

                6.4 Rest of Latin America                                                                             

7. Strategic Analysis                                                                                       

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                       

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                                              

                                7.2.5 Competitive Rivalry within the Industry                                                     

8. Market Leaders' Analysis                                                                                        

                8.1 CSL Behring                                                

                                8.1.1 Overview                                                 

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                             

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Baxter                                                           

                8.3 Biotest                                                          

                8.4 China Biologics                                                          

                8.5 Grifols                                                           

                8.6 Kedrion                                                        

                8.7 Octapharma                                                               

                8.8 Shire Plc.                                                      

                8.9 Chengdu Inst.                                                            

9. Competitive Landscape                                                                                           

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                                         

                9.4 New Product Launches                                                                         

10. Expert Opinions                                                                                        

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

Appendix                                                                                           

                a) List of Tables                                                                

                b) List of Figures                                                                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Latin America Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  2. Latin America Plasma Protein Therapeutics Market By Application From 2015-2020 (USD Billion)
  3. Latin America Immunoglobulins Market By Region, From 2015-2020 (USD Billion)
  4. Latin America Albumin Market By Region, From 2015-2020 (USD Billion)
  5. Latin America Coagulation Factors Market By Region, From 2015-2020 (USD Billion)
  6. Latin America Alpha-1 proteinase inhibitor Market By Region, From 2015-2020 (USD Billion)
  7. Latin America Others Market By Region, From 2015-2020 (USD Billion)
  8. Latin America Hemophilia Market By Region, From 2015-2020 (USD Billion)
  9. Latin America Primary Immunodeficiency Disorder Market By Region, From 2015-2020 (USD Billion)
  10. Latin America Idiopathic Thrombocytopenic Purpura Market By Region, From 2015-2020 (USD Billion)
  11. Latin America Secondary Immunodeficiency Market By Region, From 2015-2020 (USD Billion)
  12. Latin America Others Market By Region, From 2015-2020 (USD Billion)
  13. Brazil Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  14. Mexico Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  15. Rest of Latin America Plasma Protein Therapeutics Market By Type, From 2015-2020 (USD Billion)
  16. Brazil Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)
  17. Mexico Plasma Protein Therapeutics Market By Application, From 2015-2020 (USD Billion)
  18. Rest of Latin America Plasma Protein Therapeutics Market By Application From 2015-2020 (USD Billion)

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
502, Kakatiya's Empire,
Jubilee Gardens, Hyderabad,
Telangana, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.